Insulin resistance, insulin response, and obesity as indicators of metabolic risk

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 8, 2007, Pages 2885-2892

  Ferrannini, Ele ^a,i,z,af   Balkau, Beverley ^b,ac,ap   Coppack, Simon W ^c,r,ad   Dekker, Jacqueline M ^d,ae   Mari, Andrea ^e,ag,aq   Nolan, John ^f,m,ai   Walker, Mark ^g,w,ah,al   Natali, Andrea ^a,z,af   Beck Nielsen, Henning ^h,x,aj   Heine, R J ^j   Dekker, J ^j,ak   Nijpels, G ^j   Boorsma, W ^j   Mitrakou, A ^k   Tournis, S ^k   Kyriakopoulou, K ^k   Thomakos, P ^k   Lalic, N ^l   Lalic, K ^l   Jotic, A ^l   Lukic, L ^l   Civcic, M ^l   Yeow, T P ^m   Murphy, M ^m   DeLong, C ^m   Neary, G ^m   Colgan, M P ^m   Hatunic, M ^m   Konrad, T ⁿ   Bohles H ⁿ   Fuellert, S ⁿ   Baer, F ⁿ   Zuchhold, H ⁿ   Golay, A ^o   Harsch Bobbioni, E ^o   Barthassat, V ^o   Makoundou, V ^o   Lehmann, T N O ^o   Merminod, T ^o   Petrie, J R ^i,p   Perry, C ^p   Neary, F ^p   Mac Dougall, C ^p   Shields, K ^p   Malcolm, L ^p   Laakso, M ^q   Salmenniemi, U ^q   Aura, A ^q   Raisanen, R ^q   Ruotsalainen, U ^q   Sistonen, T ^q   Laitinen, M ^q   Saloranta, H ^q   McIntosh, N ^r   Khadobaksh, P ^r   Laville, M ^s   Bonnet, F ^s   De La Perriere, A Brac ^s   Louche Pelissier, C ^s   Maitrepierre, C ^s   Peyrat, J ^s   Serusclat, A ^s   Gabriel, R ^t   Sanchez E M ^t   Carraro, R ^t   Friera, A ^t   Novella, B ^t   Nilsson, P ^u   Persson, M ^u   Ostling G ^u   Melander, O ^u   Burri, P ^u   Piatti, P M ^v   Monti, L D ^v   Setola, E ^v   Galluccio, E ^v   Minicucci, F ^v   Colleluori, A ^v   Ibrahim, I M ^w   Jayapaul, M ^w   Carman, D ^w   Short, K ^w   McGrady, Y ^w   Richardson, D ^w   Staehr, P ^x   Hojlund, K ^x   Vestergaard, V ^x   Olsen, C ^x,aj   Hansen, L ^x,aj   Bolli, G B ^y   Porcellati, F ^y   Fanelli, C ^y   Lucidi, P ^y   Calcinaro, F ^y   Saturni, A ^y   Muscelli, E ^z   Pinnola, S ^z   Kozakova, M ^z,an   Mingrone, G ^aa   Guidone, C ^aa   Favuzzi, A ^aa   Di Rocco, P ^aa   Anderwald, C ^ab   Bischof, M ^ab   Promintzer, M ^ab   Krebs, M ^ab   Mandl, M ^ab   Hofer, A ^ab   Luger, A ^ab   Waldhausl W ^ab   Roden, M ^ab   Gaffney, P ^ai   Boran, G ^ai   Kok, A ^ak   Patel, S ^al   Gastaldelli, A ^am   Ciociaro, D ^am   Guillanneuf, M T ^ao   Mhamdi, L ^ap   Pacini, G ^aq   Cavaggion, C ^aq   Hills, S A ^ar   Landucci, L ^ar   Mota, L ^ar   more..

^a UNIVERSITY OF PISA   (Italy)

^b INSERM   (France)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CNR   (Italy)

^f TRINITY COLLEGE DUBLIN   (Ireland)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

^h ODENSE UNIVERSITY HOSPITAL   (Denmark)

ⁱ Department of Internal Medicine ^*

^j RISC Recruiting Centers   (Netherlands)

^k RISC Recruiting Centers   (Greece)

^l RISC Recruiting Centers   (Serbia)

^m RISC Recruiting Centers   (Ireland)

ⁿ RISC Recruiting Centers   (Germany)

^o RISC Recruiting Centers   (Switzerland)

^p RISC Recruiting Centers   (United Kingdom)

^q RISC Recruiting Centers   (Finland)

^r RISC Recruiting Centers   (Finland)

^s RISC Recruiting Centers   (United Kingdom)

^t RISC Recruiting Centers   (France)

^u RISC Recruiting Centers   (Spain)

^v RISC Recruiting Centers   (Sweden)

^w RISC Recruiting Centers   (Italy)

^x RISC Recruiting Centers   (United Kingdom)

^y RISC Recruiting Centers   (Denmark)

^z RISC Recruiting Centers   (Italy)

^aa RISC Recruiting Centers   (Italy)

^ab RISC Recruiting Centers   (Italy)

^ac Project Management Board   (Austria)

^ad Management Board   (United Kingdom)

^ae Project Management Board   (United Kingdom)

^af Project Management Board   (Netherlands)

^ag Project Management Board   (Italy)

^ah Project Management Board   (Italy)

^ai NONE   (Ireland)

^aj NONE   (Denmark)

^ak Albumin:creatinine   (Denmark)

^al Genetics   (Netherlands)

^am Stable Isotope Laboratory   (United Kingdom)

^an Ultrasound Reading Center   (Italy)

^ao ECG Reading   (Italy)

^ap Data Management   (France)

^aq Mathematical Modeling and Website Management   (France)

^ar NONE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DYSLIPIDEMIA; FACTORIAL ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; METABOLISM; MULTIVARIATE ANALYSIS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK ASSESSMENT; STANDARDIZATION; STATISTICAL MODEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 34547235853     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0334     Document Type: Article

References (40)

1. Meigs JB, D'Agostino Sr RB, Wilson PW, Cupples LA, Nathan DM, Singer DE 1997 Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 46:1594-1600
2. Ferrannini E, Haffner SM, Mitchell BD, Stern MP 1991 Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422
3. Kannel WB, Feinleib M, McNamara JR, Garrison RJ, Castelli WP 1979 An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 110:281-290
4. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven GM 1989 Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:502-506
5. Reaven GM 1988 Role of insulin resistance in human disease. Diabetes 37: 1595-1607
6. Zavaroni I, Mazza S, Fantuzzi M, Dall'Aglio E, Bonora E, Delsignore R, Passeri M, Reaven GM 1993 Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med 234:25-30
7. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM 1993 Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 92:141-146
8. Wilson PW 2003 Insulin resistance syndrome and the prothrombotic state: a Framingham perspective. Endocr Pract 9(Suppl 2):50-52
9. El-Atat FA, Stas SN, McFarlane SI, Sowers JR 2004 The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 15:2816-2827
10. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
11. Yki-Järvinen H 2005 Fat in the liver and insulin resistance. Ann Med 37:347-356
12. Iacobellis G, Corradi D, Sharma AM 2005 Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2:536-543
13. Despres JP 2006 Is visceral obesity the cause of the metabolic syndrome? Ann Med 38:52-63
14. Wajchenberg BL 2000 Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:698-738
15. Virtanen KA, Iozzo P, Hallsten K, Huupponen R, Parkkola R, Janatuinen T, Lonnqvist F, Viljanen T, Ronnemaa T, Lonnroth P, Knuuti J, Ferrannini E, Nuutila P 2005 Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study. Diabetes 54:2720-2726
16. Arner P 2005 Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19:471-482
17. Matsuzawa Y 2006 Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3:35-42
18. Berg AH, Scherer PE 2005 Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96:939-949
19. Andrew R, Westerbacka J, Wahren J, Yki-Jarvinen H, Walker BR 2005 The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans. Diabetes 54:1364-1370
20. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, Shofer JB, Fish BE, Knopp RH, Kahn SE 2004 Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53:2087-2094
21. Hills SA, Balkau B, Coppack SW, Dekker JM, Mari A, Natali A, Walker M, Ferrannini E, EGIR-RISC Study Group 2004 The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566-570
22. Andersen L, Dinesen B, Jørgensen P, Poulsen F, Røder M 1993 Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39: 578-582
23. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 2000 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 23(Suppl 1):S4-S19
24. Ferrannini E, Mari A 1998 How to measure insulin sensitivity. J Hypertens 16:895-906
25. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G 1997 Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 100:1166-1173
26. Stolk RP, Meijer R, Mali WP, Grobbee DE, der Graaf Y, Secondary Manifestations of Arterial Disease Study Group 2003 Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. Am J Clin Nutr 77:857-860
27. Ferrannini E, Mari A 2004 Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 47:943-956
28. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C 1993 Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988-1992
29. DeFronzo RA, Ferrannini E 1991 Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194
30. Walker M, Mari A, Jayapaul MK, Bennett SM, Ferrannini E 2005 Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects. Diabetologia 48:2470-2476
31. Taskinen MR 2005 Type 2 diabetes as a lipid disorder. Curr Mol Med 5:297-308
32. Reaven GM, Mondon CE 1984 Effect of in vivo plasma insulin levels on the relationship between perfusate free fatty acid concentration and triglyceride secretion by perfused rat livers. Horm Metab Res 16:230-232
33. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA 1994 Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 37:1025-1035
34. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN 2005 Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288:E454-E461
35. Bjorntorp P 2001 Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 2:73-86
36. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L 1981 Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30:219-225
37. Engeli S, Schling P, Gorzelniak K, Boscmann M, Janke J, Ailhaud G, Teboul M, Massiera F, Sharma AM 2003 The adipose-tissue renin-angiotensin- aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 35: 807-825
38. Hanley AJ, Karter AJ, Festa A, D'Agostino Jr RB, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner S 2004 Factor analysis of metabolic syndrome using directly measured insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes 51:2642-2647
39. Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, Falces C, Serrano-Rios M, Gabriel R, Shaw JE, Zimmet PZ, Haffner S 2006 A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 29:113-122
40. Lawlor DA, Ebrahim S, May M, Davey Smith G 2004 (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol 159:1013-1018